User profiles forMohammadreza Salehi

Mohammadreza Salehi

University of Amsterdam
Verified email at uva.nl
Cited by 73

Oropharyngeal candidiasis in hospitalised COVID‐19 patients from Iran: Species identification and antifungal susceptibility pattern

MSalehi, K Ahmadikia,S Mahmoudi,S Kalantari… - Mycoses, 2020 - Wiley Online Library
Background Emergence of coronavirus disease 2019 (COVID‐19) is a major healthcare threat.
Apparently, the novel coronavirus (SARS‐CoV‐2) is armed by special abilities to spread …

Low level of antifungal resistance in Iranian isolates of Candida glabrata recovered from blood samples in a multicenter study from 2015 to 2018 and potential …

…,M Lackner,H Mirhendi,MSalehi… - Antimicrobial agents …, 2019 - Am Soc Microbiol
Establishing an effective empirical antifungal therapy requires that national surveillance
studies be conducted. Herein, we report the clinical outcome of infections with and the …

The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus …

…,MI Getso,N Alijani,H Badali,H Mirhendi,MSalehi… - Mycoses, 2021 - Wiley Online Library
Acute respiratory distress syndrome is a common complication of severe viral pneumonia,
such as influenza and COVID‐19, that requires critical care including ventilatory support, use …

Low level of antifungal resistance ofCandida glabratablood isolates in Turkey: Fluconazole minimum inhibitory concentration andFKS突变can predict …

A Arastehfar,F Daneshnia,MSalehi, M Yaşar… - Mycoses, 2020 - Wiley Online Library
Background Candida glabrata is the third leading cause of candidaemia in Turkey; however,
the data regarding antifungal resistance mechanisms and genotypic diversity in association …

[HTML][HTML]Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial

M Edalatifard,M Akhtari,MSalehi… - European …, 2020 - Eur Respiratory Soc
Introduction There are no determined treatment agents for severe COVID-19. It is suggested
that methylprednisolone, as an immunosuppressive treatment, can reduce the inflammation …

Maternal death due to COVID-19

…, M Naemi,B Molaei, R Ahangari,MSalehi… - American journal of …, 2020 - Elsevier
Background Despite 2.5 million infections and 169,000 deaths worldwide (as of April 20,
2020), no maternal deaths and only a few pregnant women afflicted with severe respiratory …

Epidemiology, clinical features, diagnosis and treatment of cerebral mucormycosis in diabetic patients: a systematic review of case reports and case series

…,M Didehdar,A Khoshbayan,S Rajaeih,MSalehi… - Mycoses, 2020 - Wiley Online Library
Background Patients with diabetes are known as an important high‐risk group for cerebral
mucormycosis (CM). Method We conducted a structured search using PubMed/MEDLINE to …

[HTML][HTML]Opportunistic fungal infections in the epidemic area of COVID-19: a clinical and diagnostic perspective from Iran

MSalehi, K Ahmadikia,H Badali, S Khodavaisy - Mycopathologia, 2020 - Springer
The coronavirus disease 2019 (COVID-19) pandemic emerged in Wuhan, China, in late
2109, and has rapidly spread around the world. Until May 25, 2020, there were 133,521 …

通过产品分类和标准化进行劳动生产率测量

MSalehi,H Shirouyehzad… - International Journal of …, 2013 - inderscienceonline.com
In today’s competitive world, productivity is a fundamental concept in assessing economic
performance of organisations. Due to the fierce competition and customer requirement …

Mucormycosis in patients with COVID‐19: a cross‐sectional descriptive multicentre study from Iran

F Pakdel, K Ahmadikia,MSalehi,A Tabari, R Jafari… - Mycoses, 2021 - Wiley Online Library
Purpose The aim of the study was to report clinical features, contributing factors and outcome
of patients with coronavirus disease 2019 (COVID‐19)‐associated mucormycosis (CAM). …